BlackRock Health Sciences Trust
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2006 | 2007 | 2008 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +44.8% | -62.9% | -79.5% | +22.3% | -12.4% | +1,623.7% | -53.0% | +135.2% | -62.3% | +250.8% | -0.3% | -25.5% | -143.5% | – | -31.0% | +50.2% | |
| – | +2.7% | +3.7% | – | – | – | – | -13.5% | +9.0% | +12.6% | +12.4% | +19.5% | +23.5% | -2.8% | +1.3% | -100.0% | +7,213,483.3% | |
| – | +48.6% | -67.0% | -75.5% | +22.3% | -12.4% | +1,514.8% | -55.6% | +166.1% | -62.3% | +250.8% | -0.3% | -25.5% | -143.5% | – | -16.6% | +26.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -12.5% | -76.1% | +8,080.0% | +15.1% | +29.2% | +4.3% | -13.3% | -89.5% | +0.5% | -3.3% | +21.9% | -1.1% | -6.4% | -17.4% | +18.9% | +23.5% | |
| – | – | – | – | +125.3% | -28.2% | -61.6% | +8.3% | -98.0% | +13.9% | -7.4% | +28.5% | +1.9% | -7.6% | -21.3% | +56.8% | -7,629.5% | |
| – | +48.9% | -67.0% | -94.9% | +50.5% | -133.9% | – | -148.8% | – | -62.8% | +255.9% | -0.4% | -25.7% | -144.8% | – | +177.1% | +228.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +41.8% | +58,474.4% | |
| – | – | +34.6% | +7,397.9% | +115.7% | -27.4% | -33.9% | -148.9% | – | -62.8% | +255.9% | -0.4% | -25.7% | -144.8% | – | +17.2% | +228.2% | |
| – | – | – | – | +117.0% | -26.0% | -100.0% | – | +4,002,820.0% | -180.5% | – | -89.1% | -82.2% | +12,507.2% | +31.3% | – | – | |
| – | +48.9% | -195.4% | – | +115.7% | -27.4% | -33.9% | -148.9% | – | -62.8% | +255.9% | -0.4% | -25.7% | -144.8% | – | +17.2% | +228.2% | |
| – | – | – | – | +117.0% | -26.0% | -34.2% | -148.6% | – | -62.8% | +255.9% | -0.4% | -25.7% | -144.8% | – | +17.1% | +228.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.